Why is COVID-19 less severe in children? A review of the proposed mechanisms underlying the age-related difference in severity of SARS-CoV-2 infections.
Study Design
- Loại nghiên cứu
- Review
- Đối tượng nghiên cứu
- Children with COVID-19
- Can thiệp
- Why is COVID-19 less severe in children? A review of the proposed mechanisms underlying the age-related difference in severity of SARS-CoV-2 infections. None
- Đối chứng
- None
- Kết quả chính
- None
- Xu hướng hiệu quả
- Mixed
- Nguy cơ sai lệch
- Unclear
Abstract
In contrast to other respiratory viruses, children have less severe symptoms when infected with the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In this review, we discuss proposed hypotheses for the age-related difference in severity of coronavirus disease 2019 (COVID-19).Factors proposed to explain the difference in severity of COVID-19 in children and adults include those that put adults at higher risk and those that protect children. The former include: (1) age-related increase in endothelial damage and changes in clotting function; (2) higher density, increased affinity and different distribution of angiotensin converting enzyme 2 receptors and transmembrane serine protease 2; (3) pre-existing coronavirus antibodies (including antibody-dependent enhancement) and T cells; (4) immunosenescence and inflammaging, including the effects of chronic cytomegalovirus infection; (5) a higher prevalence of comorbidities associated with severe COVID-19 and (6) lower levels of vitamin D. Factors that might protect children include: (1) differences in innate and adaptive immunity; (2) more frequent recurrent and concurrent infections; (3) pre-existing immunity to coronaviruses; (4) differences in microbiota; (5) higher levels of melatonin; (6) protective off-target effects of live vaccines and (7) lower intensity of exposure to SARS-CoV-2.
Tóm lược
Factors that might protect children include differences in innate and adaptive immunity, more frequent recurrent and concurrent infections, pre-existing immunity to coronaviruses, and differences in microbiota.
Used In Evidence Reviews
Similar Papers
Archives of internal medicine · 2009
Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey.
Journal of autoimmunity · 2019
Systemic lupus erythematosus: Diagnosis and clinical management.
Journal of investigative medicine : the official publication of the American Federation for Clinical Research · 2011
Vitamin D and the immune system.
Gastroenterology · 2010
Primary prevention of colorectal cancer.
Journal of cachexia, sarcopenia and muscle · 2020
Osteosarcopenia: epidemiology, diagnosis, and treatment-facts and numbers.
Advances in chronic kidney disease · 2019